Home » Topics » BioWorld Science

BioWorld Science
RSS

Prognostic biomarkers of atherosclerosis and cardiovascular disease in patients with SLE

June 8, 2022

Korean research groups patent novel antioxidants

June 8, 2022

Janssen Pharmaceutica discloses MAP3K14 inhibitors

June 8, 2022

Foghorn Therapeutics describes SNF2L2/BRG1 inhibitors

June 8, 2022

University of California and University of Washington divulge IRE1 inhibitors

June 8, 2022

Southern Research Institute and UABRF report development of HO-1 modulators

June 8, 2022

Biogen and Alectos enter license and collaboration agreement for GBA2 inhibitor for Parkinson's

June 8, 2022

PineTree Therapeutics to advance oncology and viral diseases platforms

June 8, 2022

Code Biotherapeutics raises series A financing to advance programs for genetic diseases

June 8, 2022

Novel immune-competent mouse model of acute myeloid leukemia

June 8, 2022

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...